viral transport medium price

In order to effectively improve the detection efficiency of COVID-19

reduce the cost of nucleic acid detection for the masses, standardize the price behavior of nucleic acid detection in COVID-19, and implement epidemic prevention and control measures,

in August 10th, the Hunan Provincial Health Insurance Bureau Joint Provincial Health Committee,

The provincial market supervision and Administration Bureau issued the notice on further standardizing the price items of COVID-19 testing medical services (Xiangyin Bao Bao [2021] 37, hereinafter referred to as the “notice”), which has been implemented since August 11, 2021.

The original relevant price document “Supplementary Notice on COVID-19 inspection of medical services price items” (Xiang medical insurance hair [2021] 12) clearly stated that the contents of COVID-19’s testing price items were “test kit (including nucleic acid amplification reagent, nucleic acid extraction reagent or purification reagent, virus sampling tube”).

The notice on August 10 made it clear that the corresponding “exclusions” were revised to “nucleic acid detection kit (only referring to nucleic acid amplification reagent,

excluding nucleic acid extraction or purification reagent and virus sampling tube)”, and the expenses of “nucleic acid extraction or purification reagent and virus sampling tube” were included in the detection service expenses, so as to further reduce the cost burden of the masses.

After revision, the three level public hospitals COVID-19 nucleic acid detection fee standard is “50 yuan + nucleic acid amplification reagent cost (zero loss)”,

two public hospitals COVID-19 nucleic acid detection fee standard is “43 yuan + nucleic acid amplification reagent cost (zero difference)”.

According to the needs of the epidemic situation and the technical requirements and standards of the provincial health department,

20 yuan (all inclusive) will be charged for each sample, regardless of the level of medical institutions.

If the medical insurance payment policy is hospitalization, it shall be included in the reimbursement scope according to 100% of class A.

This year, Hunan and Guangdong provinces established 11 provinces alliance to carry out second rounds of new crown virus detection reagents centralized procurement.

According to the results of the centralized procurement of the alliance, the average price of the new crown virus nucleic acid amplification reagent dropped from 14.54 yuan to 8.41 yuan, with an average price reduction of 42.16%.

At present, the price of COVID-19 nucleic acid detection in three level public hospitals in our province has been reduced from an average of 69.1 yuan to 58.41 yuan per person,

and the price of two grade public hospitals has been reduced from 62.1 yuan per person to 51.41 yuan per person.

The notice requires that when carrying out mixed testing (including individual mixed sampling testing and large-scale population screening),

all public medical institutions should standardize the price behavior, charge fees according to the facts, and it is strictly prohibited to collect single inspection fees with mixed testing.

huachenyang shenzhen Technology Co., Ltd. is a leading manufacturer of diagnostic reagents for medical devices.

The price of virus sampling tubes strongly supports the global anti epidemic.

We contribute to the global epidemic, and the ex factory price really allows all customers to enjoy concessions and benefits. As long as we come to our factory to inquire about prices and products, we will reduce the discount by 10%.

If there is a larger quantity, We also support more concessions

viral transport medium price